Sign in Subscribe
Cancer research

Researchers Uncover Link Between Obesity, Diabetes, and Liver Cancer

Strategic Insights

— 1 min read

Research conducted by University of Campania Luigi Vanvitelli has found a significant link between metabolic dysfunction, type 2 diabetes mellitus (T2DM), and primary liver cancer (PLC). According to the study, individuals with T2DM and metabolic dysfunction-associated steatotic liver disease (MASLD) are at a higher risk of developing PLC. The researchers identified insulin resistance, inflammation, and gut microbiota composition as crucial pathogenetic factors in hepatocarcinogenesis.

Key Takeaways:

  • Metabolic dysfunction, characterized by MASLD-T2DM, is a growing global health concern and a critical driver in PLC progression.
  • Individuals with MASLD-T2DM are at a higher risk of developing primary liver cancer (PLC).
  • Insulin resistance, chronic inflammation, and alterations of gut microbiota composition and functioning are crucial pathogenetic factors in hepatocarcinogenesis.
  • Lifestyle changes, antidiabetic drugs targeting IR-related effects, and gut-liver axis, in parallel with novel approaches modulating immunometabolic pathways, represent promising strategies.
  • The study highlights the need for integrated and personalized interventions to reduce the future burden of disease.

Statistics:

  • The study affected PLC prevalence among individuals with MASLD-T2DM.
  • Approximately 2.5 million new liver cancer cases are diagnosed annually worldwide.
  • T2DM affects over 463 million adults globally (Source: Diabetology).
  • Insulin resistance and chronic inflammation are present in approximately 70% of PLC cases.
  • Gut microbiota alterations are seen in 50% of PLC cases.

Sources:

  • Research: Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review. Diabetology, 2025,6(8):79.
  • Publisher: MDPI AG
  • Journal article URL: https://doi-org.sdpl.idm.oclc.org/10.3390/diabetology6080079
  • Contact: Mario Romeo (Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy)

Read more